Redecil (Ointment) Instructions for Use
Marketing Authorization Holder
Retinoids JSC (Russia)
ATC Code
D10AD02 (Retinol)
Active Substances
Dioxomethyltetrahydropyrimidine (Grouping name)
Retinol (Rec.INN)
Dosage Form
| Redecil | Ointment for external use: tubes 10 g, 20 g or 35 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Retinyl palmitate | 500 mg |
| Cholecalciferol (methyluracil) | 3 g |
10 g – aluminum tubes (1) – cardboard packs.
20 g – aluminum tubes (1) – cardboard packs.
35 g – aluminum tubes (1) – cardboard packs.
Clinical-Pharmacological Group
Drug improving tissue regeneration and preventing the development of hyperkeratosis, for external use
Pharmacotherapeutic Group
Dermatoprotective agent
Pharmacological Action
Dermatoprotective agent. It stimulates skin regeneration, enhances the division of skin epithelial cells, inhibits keratinization processes, and prevents the development of hyperkeratosis.
The local action is due to the presence of specific retinol-binding receptors on the surface of epithelial cells.
Pharmacokinetics
After application, it easily penetrates the skin.
The Cmax of the active substances in the blood is reached 3-4 hours after application and is maintained for 12 hours.
T1/2 is 5.5 hours.
Indications
Ichthyosis, hyperkeratosis, seborrheic dermatitis, psoriasis, pyoderma, atopic dermatitis, neurodermatitis, eczema, frostbite, burns, erosions, ulcers, cracks, skin atrophy after long-term use of corticosteroids.
ICD codes
| ICD-10 code | Indication |
| L08.0 | Pyoderma |
| L20.8 | Other atopic dermatitis (neurodermatitis, eczema) |
| L21 | Seborrheic dermatitis |
| L28.0 | Lichen simplex chronicus (circumscribed neurodermatitis) |
| L30.0 | Nummular eczema |
| L40 | Psoriasis |
| L85.0 | Acquired ichthyosis |
| L85.1 | Acquired keratosis [keratoderma] palmaris et plantaris |
| L85.2 | Punctate keratosis (palmar-plantar) |
| R23.8 | Other and unspecified skin changes |
| T30 | Burns and corrosions of unspecified body region |
| T33 | Superficial frostbite |
| ICD-11 code | Indication |
| 9A06.70 | Atopic eczema of the eyelids |
| EA80.0 | Infantile atopic eczema |
| EA80.1 | Childhood atopic eczema |
| EA80.2 | Adult atopic eczema |
| EA80.Z | Atopic eczema, unspecified |
| EA81.Z | Seborrheic dermatitis, unspecified |
| EA82 | Nummular dermatitis |
| EA83.00 | Lichen simplex of vulva |
| EA83.01 | Lichen simplex of male genital organs |
| EA83.02 | Lichen simplex of perianal area |
| EA83.0Z | Lichen simplex of unspecified location |
| EA85.20 | Atopic hand eczema |
| EA90.Z | Psoriasis, unspecified |
| EB21 | Pyoderma gangrenosum |
| EC20.32 | Papular palmoplantar keratodermas |
| ED50.0 | Acquired ichthyosis |
| ED55.0 | Acquired palmoplantar keratodermas |
| EG00 | Dilation of skin vessels of the extremities |
| ME64 | Nonspecific cutaneous vascular signs |
| NE11 | Burn of unspecified body region |
| NE40 | Superficial frostbite |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply a thin layer of ointment to the affected skin areas twice daily, in the morning and evening.
Gently rub the ointment into the skin until fully absorbed.
The standard treatment duration is from 4 to 12 weeks, depending on the condition and severity.
Do not apply to mucous membranes or open wounds.
Wash hands thoroughly before and after application.
For extensive lesions, apply the ointment to limited areas of the skin, not exceeding 20-30% of the total body surface area.
If no improvement is observed within 2-3 weeks, or if the condition worsens, discontinue use and consult a physician.
Avoid contact with eyes. In case of accidental contact, rinse immediately with plenty of water.
Do not use occlusive dressings unless specifically directed by a doctor.
Adverse Reactions
Local reactions: increased itching, hyperemia.
Possible: allergic reactions.
The appearance of the indicated side effects requires discontinuation of the drug.
Contraindications
Hypervitaminosis A, first trimester of pregnancy, acute inflammatory skin diseases, hypersensitivity to the components of the drug.
Use in Pregnancy and Lactation
The drug is contraindicated for use in the first trimester of pregnancy.
During the lactation period (breastfeeding), it is not recommended to apply it to the skin of the mammary glands.
Drug Interactions
Should not be used in combination with other drugs containing vitamin A and retinoids to avoid hypervitaminosis A.
Incompatible with tetracycline antibiotics.
Storage Conditions
Store at 2°C (36°F) to 8°C (46°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer